Physician

Alexander Hindenburg, M.D.

According to 2025 Medicare claims, Alexander Hindenburg, M.D. (NPI: 1285684175) practices medical oncology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is NEW YORK UNIVERSITY (NPI: 1285826438; TIN: 472665045) and primary practice location at 11501-1502.

Hindenburg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 643 traditional Medicare patients, billed 2,134 HCPCS/CPT codes, and received $154,473 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 430 prescription claims across 143 beneficiaries totaling $848,071 in drug costs, led by Imbruvica (Ibrutinib). 2022 DME data shows 31 claims. Open Payments data shows 3 records totaling $71. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $88,950 to $154,473. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $1,420,693 to $848,071. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $10,259 to $1,945.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	578	1,513	$88,950
2016	683	3,731	$127,966
2017	652	2,221	$124,623
2018	614	1,970	$138,941
2019	620	2,222	$200,395
2020	560	1,510	$109,651
2021	637	1,959	$153,837
2022	597	1,791	$138,966
2023	633	1,957	$155,219
2024	643	2,134	$154,473

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	221	1,038	$1,420,693
2016	195	666	$1,038,468
2017	169	527	$600,417
2018	160	462	$410,847
2019	127	369	$64,605
2020	137	383	$147,155
2021	136	416	$527,473
2022	121	336	$388,073
2023	121	384	$748,921
2024	143	430	$848,071

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	24	355	$73,192
2016	N/R	152	$24,587
2017	N/R	N/R	N/R
2018	N/R	37	$4,589
2019	N/R	19	$129
2020	N/R	N/R	N/R
2021	N/R	37	$993
2022	N/R	31	$1,313
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	67	67	$147
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	56	63	$144
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	252	614	$106
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	410	665	$75
36415	Insertion of needle into vein for collection of blood sample	315	532	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	25	756	$436,459
Verzenio	Abemaciclib	16	678	$336,073
Exemestane	Exemestane	38	2,220	$4,886
Letrozole	Letrozole	147	11,708	$3,091
Tamoxifen Citrate	Tamoxifen Citrate	43	2,790	$510

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$71	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexander Hindenburg, M.D.?

Tedicare shows public-source Medicare data for Alexander Hindenburg, M.D. (NPI 1285684175), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Hindenburg, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexander Hindenburg, M.D.?

Alexander Hindenburg, M.D. is linked to NEW YORK UNIVERSITY (billing NPI 1285826438) in the available physician profile data.

Does Alexander Hindenburg, M.D. have Open Payments data?

Alexander Hindenburg, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.